Tuebingen, Germany

Franziska Hoffgaard

USPTO Granted Patents = 76 

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 23(Granted Patents)

Forward Citations (Not Self Cited) = 8(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Tübingen, DE (2021)
  • Tuebingen, DE (2020 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
T Cell Receptors
Immunotherapy
Peptides
Non-Canonical Peptides
Cancer Treatment
HLA-A*02
Peptide Combinations
Amidated Peptides
76 patents (USPTO):Explore Patents

Title: Franziska Hoffgaard: Innovator in Immunotherapy

Introduction: Franziska Hoffgaard is a renowned inventor based in Tuebingen, Germany, recognized for her significant contributions to the field of immunotherapy. With an impressive portfolio of 75 patents, she has been at the forefront of developing innovative solutions in the fight against cancer.

Latest Patents: Among her latest patent contributions, Hoffgaard has focused on peptides for use in immunotherapy against cancers. These inventions encompass a diverse array of peptides, proteins, nucleic acids, and cells that are employed in immunotherapeutic methods. Notably, her work involves tumor-associated T-cell peptide epitopes that may serve as active pharmaceutical ingredients in vaccine compositions. These vaccines aim to stimulate anti-tumor immune responses and can enhance T cells ex vivo for patient transfer. Additionally, Hoffgaard has developed amidated peptides and their deamidated counterparts displayed by HLA-A*02 to target various cancers, showcasing her commitment to advancing cancer treatment through innovative peptide technologies.

Career Highlights: Hoffgaard's career is marked by her dedication to research and her pioneering work in the field of biotechnology. As an inventor at Immatics Biotechnologies GmbH, she leverages her expertise to push the boundaries of cancer immunotherapy. Her substantial record of patents underscores her role as a leader in biotechnological innovation.

Collaborations: Throughout her career, Hoffgaard has worked collaboratively with several esteemed professionals, including Oliver Schoor and Jens Fritsche. These collaborative efforts have further enriched her research and contributed to the company’s advancements in the field.

Conclusion: Franziska Hoffgaard exemplifies the spirit of innovation in the biotechnology sector, particularly in immunotherapy for cancer. Her extensive portfolio and collaborative work drive the evolution of therapeutic strategies to combat cancer, establishing her as a significant figure in the realm of modern medicine. Her contributions through Immatics Biotechnologies GmbH continue to inspire advancements in the treatment of cancer through immunological approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…